Countries respond to link made between AstraZeneca vaccine and blood clots

The European Medicines Agency remains adamant the benefits of the AstraZeneca COVID-19 vaccine outweigh the risks. Countries across Europe are now deciding on their own what to do next.

A doctor with an AstraZeneca vaccine container at a vaccination center in Bucharest, Romania. Source: AAP

For health and support measures currently in place in response to the COVID-19 pandemic in your language, visit sbs.com.au/coronavirus